The Relationship Between Chronic Fatigue Syndrome and Depression: Mediating Roles of Executive Functions in Patients with Relapsing-Remitting Multiple Sclerosis

Authors

  • Abdorreza Naser Moghadasi Neurologist, Multiple Sclerosis Research Center, Neuroscience Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Jalil Fathabadi Department of Applied Psychology, Faculty of Education and Psychology, Shahid Beheshti University, Tehran, Iran.
Abstract:

This study aimed to investigate the relationship between chronic fatigue syndrome (CFS) and depression with the mediating role of executive functions (EFs) in patients with relapsing-remitting multiple sclerosis (RRMS). The statistical population of this descriptive correlational study included all patients with RRMS who were referred to Tehran neurologists in the summer of 2021 and among them, 208 samples who were eligible to enter the study, were selected via available sampling methods. To collect data, Krupp et al.'s (1988) Fatigue Severity Scale (FSS), Nejati's Cognitive Abilities (NCA), and Beck Depression Inventory (II-BDI) were used. Pearson correlation method and structural equation modeling (SEM) were used to analyze the data. Of the seven subscales of EFs, the subscales of working memory, inhibitory control, selective attention, planning, and cognitive flexibility, which are called "cold" processes of EFs, were approved as mediators at the level (P <0.001), but the subscales of cognitive functioning, decision-making and controlled attention, which are hot functions and require emotional awareness and regulation of personal social behaviors and decision-making with emotional and personal interpretation and empathy, were not approved as mediating roles. The results also showed that in patients with RRMS, there was a significant relationship between CFS and depression, between CFS and EFs, and between EFs and depression (P <0.001). The results of the present study can be used in cognitive rehabilitation to improve EFs and consequently improve depression in patients with MS.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Comparing the Safety and Efficacy of Ziferon and Betaferon in Patients With Remitting-Relapsing Multiple Sclerosis

Background: The present study aimed to compare the clinical efficacy and safety profile of Ziferon and Betaferon. Objectives: In total, 41 consecutive patients with relapsing forms of Multiple Sclerosis (MS) were selected from the MS outpatient clinic affiliated to Tehran University of Medical Sciences. The patients were randomly assigned into two groups. Methods: Each group either received Z...

full text

The relationship between body image and depression in women diagnosed with relapsing remitting multiple sclerosis.

Little is known about perceptions of body image in women diagnosed with relapsing remitting multiple sclerosis (RRMS). This descriptive correlational study was conducted to describe how women perceive their body image while living with RRMS, and to examine a potential relationship between body image and depression in women who have RRMS. A convenience sample of 30 women from a western Canadian ...

full text

Safety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis

Introduction: Fingolimod is the first confirmed oral immune-modulator to treat Relapsing-Remitting Multiple Sclerosis (RRMS). This study aimed to investigate the safety and efficacy of fingolimod therapy in Iranian patients with RRMS. Methods: In our trial, 50 patients resistant to conventional interferon therapy were assigned to receive fingolimod 0.5 mg per day for 12 months. The number of D...

full text

impaired working memory in patients with mild disabled relapsing-remitting multiple sclerosis and it’s relation with depression and fatigue

the multiple sclerosis (ms) is a chronic disease of cns leads to some dysfunctions including cognitive (working memory), mood (depression) and fatigue. in spite of previous investigations about working memory impairment in patients with ms, there are scare evidences for working memory dysfunction in mild disabled ms patients (edss

full text

Increased Expression of miR-202-3p in Patients with Relapsing-Remitting Multiple Sclerosis

Background and objectives: One of the latest studies in the genetics field is the evaluation of role of micro-RNAs as a biomarker for diagnosis of multiple sclerosis (MS), which is a demyelinating disease of the central nervous system (CNS) and emerges in the form of numerous small and large plaques in white matter in the brain and spinal cord. This disease could be associated with several comp...

full text

Circadian cortisol and fatigue severity in relapsing-remitting multiple sclerosis

Cortisol is a key regulator of the immune system, energy metabolism, and stress, yet its relevance to fatigue experienced by people with relapsing-remitting multiple sclerosis (RRMS) remains uncertain. We examined cortisol secretory activity in RRMS and its association with fatigue severity between-individuals and within-individuals (day-to-day) using a case-control ecological momentary assessm...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 10  issue 4

pages  0- 0

publication date 2022-10

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023